Home Industry Reports Custom Research Blogs About Us Contact us

Intracranial Stenosis Stents Market Size & Share, By Product (Self-expanding Stents, Embolization Coil Support Intracranial Stents, Venous Sinus Stents, Balloon-expanding), End-use, Regional Forecast, Industry Players, Growth Statistics Report 2023-2030

Report ID: FBI 1213


Published Date: Aug-2023


Format : PDF, Excel

Market Outlook:

Intracranial Stenosis Stents Market size surpassed USD 0.75 Billion in 2022 and is poised to reach USD 1.21 Billion, growing at over 5.52% CAGR between 2023 and 2030. This market valuation can be attributed to several key factors, including an increasing prevalence of intracranial stenosis, advancements in stent technology, rising surgical interventions for the treatment of cerebrovascular diseases, and the growing geriatric population.

Base Year Value (2022)

USD 0.75 Billion

18-23 x.x %
24-33 x.x %

CAGR (2023-2030)


18-23 x.x %
24-33 x.x %

Forecast Year Value (2030)

USD 1.21 Billion

18-23 x.x %
24-33 x.x %
Intracranial Stenosis Stents Market

Historical Data Period


Intracranial Stenosis Stents Market

Largest Region

North America

Intracranial Stenosis Stents Market

Forecast Period


Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunities:

1. Increasing Prevalence of Intracranial Stenosis: The rising incidence of intracranial stenosis, which is predominantly observed in the aging population, is a significant driver for the market. Factors such as high blood pressure, diabetes, obesity, and smoking contribute to the development of intracranial stenosis, thereby boosting the demand for stent implants.

2. Advancements in Stent Technology: Technological advancements in intracranial stenosis stents have greatly improved their efficacy and safety. The introduction of self-expanding stents and drug-eluting stents has led to enhanced patient outcomes, lower rates of complications and restenosis, and increased adoption of these devices.

3. Rising Surgical Interventions: The increasing number of surgical interventions for the treatment of cerebrovascular diseases, including intracranial stenosis, is driving the demand for stents. With the growing awareness about the benefits of stenting procedures, both patients and healthcare professionals are opting for these minimally invasive treatments to improve patient outcomes.


Industry Restraints & Challenges:

Report Scope

Report CoverageDetails
Segments CoveredProduct, End-Use, Region
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiledphenox GmbH, Medtronic, Acandis GmbH, MicroPort Scientific, MicroVention, CERENOVUS (Johnson & Johnson), Sino Medical Sciences Technology, Stryker, Balt

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

1. High Cost of Intracranial Stenosis Stenting: The high costs associated with intracranial stenosis stenting procedures, including the cost of stents, deployment devices, and post-operative care, pose a challenge for market growth. The affordability and reimbursement policies in different regions also impact the adoption of these stents.

2. Lack of Skilled Professionals: Performing intracranial stenting procedures requires a high level of expertise and skill. However, there is a shortage of skilled healthcare professionals proficient in these techniques, limiting the availability and accessibility of these treatments.

3. Potential Risks and Complications: Although intracranial stenosis stents have proven to be effective, they still carry the risk of complications such as restenosis, stent thrombosis, and stent migration. These complications, in addition to the potential risks associated with any surgical procedure, can hinder the market growth.

In conclusion, the global intracranial stenosis stents market is poised for significant growth in the coming years. The growing prevalence of intracranial stenosis, advancements in stent technology, increased surgical interventions, and the aging population are the primary drivers for this market. However, the high costs of stenting procedures, shortage of skilled professionals, and potential risks and complications may pose challenges to market growth.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Intracranial Stenosis Stents Market
Intracranial Stenosis Stents Market

Regional Forecast:

The intracranial stenosis stents market is expected to witness substantial growth in the forecast period in North America, Asia Pacific, and Europe.

North America

In North America, the increasing prevalence of cardiovascular diseases, rising geriatric population, and the presence of a well-established healthcare infrastructure are driving the market growth. Additionally, the swift adoption of advanced technologies and the high demand for minimally invasive procedures contribute to the growth of the intracranial stenosis stents market in North America.

Asia Pacific

In Asia Pacific, the market is expanding at a significant rate due to the growing patient population, increasing awareness about minimally invasive procedures, and the improving healthcare infrastructure in countries like China and India. Furthermore, the rise in healthcare expenditure, the presence of untapped opportunities, and rising disposable income in these regions are expected to fuel market growth.


In Europe, the market is driven by factors such as the rising prevalence of neurological disorders, advancements in stent technology, and the growing geriatric population. Moreover, the supportive reimbursement policies and increasing research and development activities in the region also contribute to the growth of the intracranial stenosis stents market.

Get more details on this report -

Segmentation Analysis:

Angioplasty Balloon Catheters

Angioplasty balloon catheters are a sub-segment of the intracranial stenosis stents market. These catheters are used to dilate and open narrowed or blocked blood vessels in the brain. They are inserted into the stenotic artery and inflated to restore blood flow. The increasing prevalence of intracranial stenosis and the rising demand for minimally invasive procedures are driving the adoption of angioplasty balloon catheters. Additionally, the advancements in catheter technology, such as the development of drug-eluting balloon catheters, further contribute to their market growth.

Get more details on this report -

Competitive Landscape:

 Abbott Laboratories, Medtronic, Inc., Boston Scientific Corporation, and Stryker Corporation

Abbott Laboratories, Medtronic, Inc., Boston Scientific Corporation, and Stryker Corporation are some of the key players in the intracranial stenosis stents market. These companies focus on strategic partnerships, collaborations, and acquisitions to strengthen their market position. They also invest heavily in research and development activities to develop innovative and technologically advanced stents for the treatment of intracranial stenosis. The market players adopt various growth strategies to gain a competitive edge in the market and expand their product portfolio.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Intracranial Stenosis Stents Market Size & Share, ...

RD Code : 24